SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-003903
Filing Date
2015-05-11
Accepted
2015-05-11 16:06:54
Documents
13
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cala-10q_20150331.htm 10-Q 1160860
2 EX-10.17 cala-ex1017_20150331327.htm EX-10.17 597058
3 EX-31.1 cala-ex311_201503318.htm EX-31.1 11573
4 EX-31.2 cala-ex312_201503317.htm EX-31.2 11536
5 EX-32.1 cala-ex321_201503316.htm EX-32.1 6004
6 EX-32.2 cala-ex322_201503319.htm EX-32.2 6211
7 GRAPHIC g201505111544312631789.jpg GRAPHIC 11058
  Complete submission text file 0001564590-15-003903.txt   5922264

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cala-20150331.xml EX-101.INS 867052
9 XBRL TAXONOMY EXTENSION SCHEMA cala-20150331.xsd EX-101.SCH 26884
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cala-20150331_cal.xml EX-101.CAL 27647
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cala-20150331_def.xml EX-101.DEF 61694
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cala-20150331_lab.xml EX-101.LAB 194727
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cala-20150331_pre.xml EX-101.PRE 150396
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36644 | Film No.: 15850716
SIC: 2834 Pharmaceutical Preparations